Serum Institute seeks DGCI’s approval for Covishield booster dose

New Delhi, Dec 01: Serum Institute of India has sought from India’s drug regulator approval for Covishield as a booster dose citing adequate stock of the vaccine in the country and a demand for a booster shot due to the emergence

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News